Frontage Holdings Corporation is a contract research organization specializing in laboratory and research services for the pharmaceutical, biotechnology, and agrochemical sectors. Its core offerings s... Frontage Holdings Corporation is a contract research organization specializing in laboratory and research services for the pharmaceutical, biotechnology, and agrochemical sectors. Its core offerings span the entire drug development lifecycle, including drug discovery, preclinical and clinical development, and laboratory testing services. Notable capabilities include medicinal chemistry, pharmacology, absorption, distribution, metabolism, and excretion (ADME) studies, as well as drug metabolism and pharmacokinetics (DMPK), safety and toxicology assessments, and early phase clinical support. The company also provides analytical, bioanalytical, genomics, and central laboratory services, supporting clients from lead optimization to clinical trial material manufacturing and regulatory submissions. Headquartered in Exton, Pennsylvania, Frontage Holdings operates across North America, China, and other global markets. As a subsidiary of Hongkong Tigermed Co., Limited, it serves a broad roster of customers in the life sciences, chemical, and animal health industries, enabling efficient, compliant, and innovative drug development worldwide.
Frontage Holdings is not subject to EU Taxonomy reporting
Based on current regulatory requirements, Frontage Holdings is not required to report EU
Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU
Taxonomy data review for this company.
If you believe this assessment should be revisited, you may submit a data coverage request
and our team will review the company's regulatory applicability.